419 related articles for article (PubMed ID: 29871641)
1. Parthenolide attenuated bleomycin-induced pulmonary fibrosis via the NF-κB/Snail signaling pathway.
Li XH; Xiao T; Yang JH; Qin Y; Gao JJ; Liu HJ; Zhou HG
Respir Res; 2018 Jun; 19(1):111. PubMed ID: 29871641
[TBL] [Abstract][Full Text] [Related]
2. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
3. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
4. Ephedrine alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and restraining NF-κB signaling.
Tian H; Wang L; Fu T
J Toxicol Sci; 2023; 48(10):547-556. PubMed ID: 37778983
[TBL] [Abstract][Full Text] [Related]
5. Imrecoxib Inhibits Paraquat-Induced Pulmonary Fibrosis through the NF-
Jin H
Comput Math Methods Med; 2020; 2020():6374014. PubMed ID: 33123215
[TBL] [Abstract][Full Text] [Related]
6. Sinomenine attenuates pulmonary fibrosis by downregulating TGF-β1/Smad3, PI3K/Akt and NF-κB signaling pathways.
Yao F; Xu M; Dong L; Shen X; Shen Y; Jiang Y; Zhu T; Zhang C; Yu G
BMC Pulm Med; 2024 May; 24(1):229. PubMed ID: 38730387
[TBL] [Abstract][Full Text] [Related]
7. Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways.
Xiong Y; Cui X; Zhou Y; Chai G; Jiang X; Ge G; Wang Y; Sun H; Che H; Nie Y; Zhao P
Int Immunopharmacol; 2021 Sep; 98():107780. PubMed ID: 34118645
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition.
Zhang LM; Zhang Y; Fei C; Zhang J; Wang L; Yi ZW; Gao G
Biochem Biophys Res Commun; 2019 Jan; 508(2):660-666. PubMed ID: 30527805
[TBL] [Abstract][Full Text] [Related]
11. Tetraspanin 1 inhibits TNFα-induced apoptosis via NF-κB signaling pathway in alveolar epithelial cells.
Yang L; Wang Y; Pan Z; Gao S; Zou B; Lin Z; Feng D; HuangFu C; Liu G
Inflamm Res; 2018 Dec; 67(11-12):951-964. PubMed ID: 30291375
[TBL] [Abstract][Full Text] [Related]
12. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
[TBL] [Abstract][Full Text] [Related]
13. S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice.
Nie Y; Yu K; Li B; Hu Y; Zhang H; Xin R; Xiong Y; Zhao P; Chai G
J Pharmacol Sci; 2019 Apr; 139(4):377-384. PubMed ID: 30928090
[TBL] [Abstract][Full Text] [Related]
14. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
Tan ZX; Chen YH; Xu S; Qin HY; Zhang C; Zhao H; Xu DX
Toxicol Lett; 2016 Jan; 240(1):161-71. PubMed ID: 26520185
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin inhibits the activation of lung fibroblasts and pulmonary fibrosis by regulating the nuclear factor kappa B (NF-κB) pathway.
Wang X; Yang J; Wu L; Tong C; Zhu Y; Cai W; Wan B; Zhang X
Bioengineered; 2022 Apr; 13(4):10098-10110. PubMed ID: 35435119
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis.
Zhou W; Mo X; Cui W; Zhang Z; Li D; Li L; Xu L; Yao H; Gao J
Sci Rep; 2016 Dec; 6():38646. PubMed ID: 27982105
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
19. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
[TBL] [Abstract][Full Text] [Related]
20. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
Rong L; Wu J; Wang W; Zhao RP; Xu XW; Hu D
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2144-50. PubMed ID: 27249616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
